Global 
Australia 
België 
Deutschland 
España 
France 
Ireland 
Italia 
Luxembourg 
Nederland 
Österreich 
Portugal 
Россия 
Schweiz 
United Kingdom 
Jorveza®
Jorveza® is an orodispersible tablet containing the topically acting corticosteroid budesonide. The formulation has been specifically developed for the targeted treatment of Eosinophilic Oesophagitis (EoE) and is the first and only oral steroid currently licensed in the UK and globally for this condition.
Summary of Product Characteristics (SmPC)
For further information, the Summary of Product Characteristics (SmPC) is available below.
Jorveza® 0.5mg orodispersible tablet
Jorveza® 1mg orodispersible tablet
Patient Resources
Patient - IBD
Patient - Ursofalk
Patient - Salofalk
Patient - Jorveza
Patient - Budenofalk
HCP
HCP - Budenofalk
HCP - EoE
HCP - IBD
HCP - Jorveza
HCP - Liver Disease
HCP - Salofalk
HCP - Ursofalk
Dr. Falk Atlas - GI & liver conditions explained
HCP - EoE
Patient - EoE
Patient - IBD
Patient
Patient - Salofalk
HCP - Jorveza
Patient - Jorveza
What Happens After Your Gastroscopy - Dr L. Al Rubaiy
HCP - Salofalk
HCP - Jorveza
Patient
Patient - EoE
Patient - IBD
Patient - Salofalk
Patient - Jorveza
How To Prepare For A Gastroscopy - Dr L. Al Rubaiy
HCP - Salofalk
HCP - Jorveza
Patient - Salofalk
Patient - EoE
Patient - Jorveza
Patient
Patient - IBD
Gastroscopy Reasons & Risks - Dr L. Al Rubaiy
HCP - Jorveza
HCP - Salofalk
Patient - EoE
Patient - IBD
Patient - Jorveza
Patient
Patient - Salofalk
How To Prepare For A Colonoscopy - Dr L. Al Rubaiy
HCP - Jorveza
HCP - Salofalk
Patient
Patient - EoE
Patient - IBD
Patient - Jorveza
Patient - Salofalk
Colonoscopy Reasons & Risks - Dr L. Al Rubaiy
HCP
HCP - IBD
HCP - Salofalk
HCP - EoE
HCP - Jorveza
Patient - EoE
Patient - Jorveza
Having a Colonoscopy - Dr L. Al Rubaiy
HCP - EoE
HCP - Jorveza
Patient - Jorveza